Jeffrey W Sherman Horizon Therapeutics Public LTD CO (HZNP) insider trading activity

Jeffrey W Sherman is EVP and Chief Medical Officer of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 0 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Mar 23, 2016, when has been sold 8,798 shares (Ordinary Shares) at a price of $16.32 per share, resulting in proceeds of $143,583. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

JEFFREY W SHERMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 23 2016	SELL Payment of exercise price or tax liability	$143,583 $16.32 p/Share	8,798 Reduced 5.21%	160,100 Ordinary Shares
Mar 23 2016	BUY Exercise of conversion of derivative security	-	19,250 Added 10.23%	168,898 Ordinary Shares
Feb 26 2016	SELL Open market or private sale	$82,000 $20.0 p/Share	4,100 Reduced 2.67%	149,648 Ordinary Shares
Jan 02 2016	SELL Payment of exercise price or tax liability	$185,842 $21.67 p/Share	8,576 Reduced 5.28%	153,748 Ordinary Shares
Jan 02 2016	BUY Exercise of conversion of derivative security	-	26,750 Added 14.15%	162,324 Ordinary Shares
Dec 15 2015	BUY Exercise of conversion of derivative security	$112,027 $3.68 p/Share	30,442 Added 18.34%	135,574 Ordinary Shares
Dec 10 2015	BUY Open market or private sale	$89,120 $20.0 p/Share	4,456 Added 4.07%	105,132 Ordinary Shares
Dec 08 2015	SELL Payment of exercise price or tax liability	$80,293 $21.4 p/Share	3,752 Reduced 3.31%	109,588 Ordinary Shares
Dec 08 2015	BUY Exercise of conversion of derivative security	-	8,208 Added 6.75%	113,340 Ordinary Shares
Sep 21 2015	SELL Open market or private sale	$246,295 $31.78 p/Share	7,750 Reduced 6.87%	105,132 Ordinary Shares
Jul 15 2015	SELL Open market or private sale	$955,833 $35.55 p/Share	26,887 Reduced 19.24%	112,882 Ordinary Shares
Jul 15 2015	BUY Exercise of conversion of derivative security	$98,944 $3.68 p/Share	26,887 Added 18.91%	115,332 Ordinary Shares
Jan 02 2015	SELL Payment of exercise price or tax liability	$112,038 $12.8 p/Share	8,753 Reduced 7.88%	102,333 Ordinary Shares
Jan 02 2015	BUY Exercise of conversion of derivative security	-	26,750 Added 19.41%	111,086 Ordinary Shares
Dec 08 2014	SELL Payment of exercise price or tax liability	$34,501 $12.99 p/Share	2,656 Reduced 3.05%	84,336 Ordinary Shares
Dec 08 2014	BUY Exercise of conversion of derivative security	-	8,208 Added 8.62%	86,992 Ordinary Shares
Nov 19 2014	SELL Open market or private sale	$301,238 $12.05 p/Share	24,999 Reduced 25.18%	74,299 Ordinary Shares

Also insider at

SBBP

Strongbridge Biopharma plc

Director

XERS

XERIS PHARMACEUTICALS INC Healthcare

Director

XERS

Xeris Biopharma Holdings, Inc. Healthcare

Director

LRMR

Larimar Therapeutics, Inc. Healthcare

Director

JWS